AlmgärdL. E., FernströmI., HavkrusgH., LjungquistA.: Treatment of renal adenocarcinoma by embolic occlusion of the renal circulation. Brit. J. Urol., 45; 474 (1973).
2.
BichlerK. H., AxW., TautzC.: Cell-mediated immunity in patients with renal adenocarcinoma. Eur. Urol., 1; 231 (1975).
3.
BrachenR. B., JohnsonD. E., GoldsteinH. M.: Percutaneous transfemoral renal artery occlusion in patients with renal carcinoma. Preliminary report. Urology, 6; 6 (1975).
4.
BrcsmanS., HausmanM., ShacksS. J.: Studies on the immune status of patients with renal adenocarcinoma. J. Urol., 114; 375 (1975).
5.
BubenikJ., JakoubkovaJ., FrakoraP., BresoyaM., HelbichP., VikickyV., MalaskovaC.: Cellular immnunity to renal carcinomas in man. Intern. J. Cancer, 8; 503 (1971).
6.
CatalonaW. J., SampleW. F., ChretienP. B.: Lymphocyte reactivity in cancer patients: correlation with tumor histology and clinical stage. Cancer, 31; 65 (1973).
7.
CatalonaW. J., TarpleyJ. L., ChretienP. B., CastleR. J.: Lymphocyte stimulation in urologic cancer patients. J. Urol., 112; 373 (1974).
8.
ChaputB., RellaW., VetterleinM.: Changes in cell-mediated immune functions by growing tumor. Eur. J. Cancer., 10; 185 (1974).
9.
ColeA. T., AvisI., FriedF. A., AvisF.: Cell-mediated immunity in renal cell carcinoma. Preliminary report. J. Urol., 115; 234 (1976).
10.
EisenbergerF., MarxF. J., SchmiedtE.: Die transfemorale Kanülierung der Nierengefässe. Diagnostisch-therapeutische Anwendungs Möglichkeiten bei urologischen Erkrankungen. Urologe A, 16; 1 (1977).
11.
ElhilaliM. M., BrittonS., BrosmanS., FaheyJ. L.: Critical evaluation of lymphocyte functions in uorolgical cancer patients. Cancer Res., 36; 132 (1976).
12.
FerrariniM., TondaG. P., RissoA., VialeG.: Lymphocyte membrane receptors in human lymphoid leukemias. Eur. J. Immunol., 5; 89 (1975).
GiulianiL., CarmignaniG., BelgranoE., PuppoP.: L'embolizzazione in urologia. Rel. Uff. Convegno Urologi Lombardi, Milano 1977. Arch. it. Urol., 49; 5 (1977).
15.
ManconiP. E., Del GiaccoG. S., TocnellaS., MantovaniG., FaddaM. F., CornagliaP., LeoneD. C., ZaccheoD., GrifoniV.: Effetto della PHA sulla formazione di rosette da parte di linfociti periferici umani. Boll. Ist. Sieroter. milanese, 54; 305 (1975).
16.
Mc LaughlinA. P., KesslerW. O., TrimanK., GittesR. F.: Immunologie competence in patients with urologie cancer. J. Urol., 111; 233 (1974).
17.
McLaughlinA. P., BrooksJ. P.: A plasma factor inhibiting lymphocyte reactivity in urologie cancer patients. J. Urol., 112; 366 (1974).
18.
MontieJ. E., StraffonR. A., DeodharS. D., BarnaB.: In vitro assessment of cell-mediated immunity in patients with renal cell carcinoma. J. Urol., 115; 239 (1976).
19.
WhitneyR. B., LevyJ. G., SmithA. G.: Influence of tumor size and surgical resection on cell-mediated immunity in mice. J. Nat. Cancer Inst., 53; 111 (1974).